ACLU Fights Myriad's Bid For Cancer-Test Sales Ban
The American Civil Liberties Union and other groups that successfully invalidated Myriad Genetics Inc.'s isolated DNA patents in a U.S. Supreme Court case last year, urged the Federal Circuit on Monday to...To view the full article, register now.
Already a subscriber? Click here to view full article